2012
DOI: 10.1016/j.jpain.2012.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Responsiveness of Pain Measures in Cancer Patients

Abstract: Brief measures to assess and monitor pain in cancer patients are available, but few head-to-head psychometric comparisons of different measures have been reported. Baseline and 3-month data were analyzed from 274 patients enrolled in the Indiana Cancer Pain and Depression (INCPAD) trial. Participants completed the Brief Pain Inventory (BPI), the PEG (a 3-item abbreviated version of the BPI), the short form (SF)-36 pain scale, and a pain global rating of change measure. The global rating was used as the criteri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
23
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 43 publications
(31 citation statements)
references
References 57 publications
5
23
1
Order By: Relevance
“…The BPI has well-established validity and reliability among patients with cancer, including sensitivity to change in longitudinal studies. 19,22,59 In this study, Cronbach's alpha for the BPI interference scale was 0.92.…”
Section: Brief Pain Inventorymentioning
confidence: 49%
“…The BPI has well-established validity and reliability among patients with cancer, including sensitivity to change in longitudinal studies. 19,22,59 In this study, Cronbach's alpha for the BPI interference scale was 0.92.…”
Section: Brief Pain Inventorymentioning
confidence: 49%
“…For example, the BPI-PI has been found to correlate highly with the WHO Disability Assessment Schedule 2.0 (0.69 to 0.81, from one to 12 months),[20] to discriminate between recurrent and non-fallers (sensitivity = 84.4% and specificity = 57.8% with a cutoff score of 4.6)[21] , and to have good inter-item consistency (alpha=0.89) and responsiveness (standardized response mean = .91). [22] The measure has been used in a substantial range of diseases and conditions and has been translated into many languages. [23] Developed using traditional methods, the BPI produces pain severity and pain interference scores that range from 0 to 10, with higher scores indicating worse pain.…”
Section: Methodsmentioning
confidence: 99%
“…The BPI total score is a composite of the pain and interference scores and served as the primary outcome; it has proven sensitive to change in previous trials. 17,18 BPI scale scores range from 0 to 10, with higher scores representing worse pain and a 1-point change considered clinically important. 17,19 The primary outcome was the mean between-group difference in BPI total score during the 12-month trial.…”
Section: Outcome Measuresmentioning
confidence: 99%